Initial Data from Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia to be Presented, Along with Initial Findings ...

A groundbreaking review out of the UK finds “poor” or “low quality” evidence for using puberty blockers and hormones to help ...

Dr. Anand Thakker from Chicago Weight Loss and Vitality Clinic is back with us tonight to talk about the low testosterone ...

The peak fertility age for women is 23. But many aren't planning on having kids until their 30s - leading to some tectonic ...

In terms of liquidity and interest, the mean open interest for Viking Therapeutics options trades today is 783.0 with a total ...

Ojemda treatment for certain patients with pediatric low-grade glioma is “well-tolerated” and may be safer than traditional ...

Published preclinical data in Cell Stem Cell demonstrating that HIP-modified allogeneic islet cells provided lasting endocrine function in a fully immunocompetent non-human primate with type 1 ...

In a report released today, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Crinetics Pharmaceuticals (CRNX – Research ...

Completed enrollment in 60-patient Phase 1b/2 clinical studies of palazestrant in combination with each of ribociclib and palbociclibNew clinical data from palazestrant-ribociclib combination study to ...

Major medical organizations, including the American Academy of Pediatrics and the Endocrine Society, endorse the use of puberty blockers and hormone therapies for transgender youth under appropriate ...

Nobody wants their car seats to go up in flames, but new research indicates that flame retardant chemicals used to prevent ...

State lawmakers in the House voted unanimously Tuesday evening to advance a Senate bill prohibiting the use of hazardous “forever chemicals” in certain household products and textiles.